EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal stem cell derived exosome promotes the viability of ameloblast-like cells

Bardia Mortezagholi, Esmaeel Dadgar, Sadaf Saeidi, Leila Rajaei Behbahani, Alireza Firouzi, Omolbanin Rezayee Mehr, Emad Movahed

Nanomedicine Research Journal · 2023-04 · 8 (2) · 186-192

DOI: 10.22034/nmrj.2023.02.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomedicine Research Journal, 2023-04. Verfasst von Bardia Mortezagholi und 6 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective(s): To assess the effects of the exosome produced by mesenchymal stem cells (MSCs) on ameloblast-like cells' capacity to proliferate.

Methods

The exosomes were isolated from the human BM-MSCs and characterized by TEM images and western blotting. Then ALC cells were exposed with the increasing concentration of the exosome within 12, 24, 48 and 72 hours of treatment. Then, the cell viability was assessed by MTT assay. Also, the expression levels of the cyclin A, cyclin B, PI3K/AKT and FOXO3 were measured by real-time PCR upon cell exposure with 40 ng/ml exosome within 24-72 hours of treatment.

Results

BM-MSCs-exosome could to promote the viability of ALC cells, in particular, at higher concentrations. Also, therapy resulted in an increased level of cyclin A/B, PI3K, AKT and FOXO3 in treated cell, more evidently within 72 hours of treatment.

Conclusions

We showed that MSCs-derived exosome as natural nanoparticles could improve the viability of ameloblast-like cells by promoting cell cycle arrest and activating P3K/AKT pathway.

Schlagwörter

mesenchymal stem cellviabilitypi3k/aktcyclin a and cyclin b

Zitieren

APA

Mortezagholi, B., Dadgar, E., Saeidi, S., Behbahani, L. R., Firouzi, A., Mehr, O. R., & Movahed, E. (2023). Mesenchymal stem cell derived exosome promotes the viability of ameloblast-like cells. Nanomedicine Research Journal, 8(2), 186-192. https://doi.org/10.22034/nmrj.2023.02.008

Vancouver

Mortezagholi B, Dadgar E, Saeidi S, Behbahani LR, Firouzi A, Mehr OR, et al. Mesenchymal stem cell derived exosome promotes the viability of ameloblast-like cells. Nanomedicine Research Journal. 2023;8(2):186-192. doi:10.22034/nmrj.2023.02.008

BibTeX
@article{Mortezagholi2023,
  author = {Mortezagholi, Bardia and Dadgar, Esmaeel and Saeidi, Sadaf and Behbahani, Leila Rajaei and Firouzi, Alireza and Mehr, Omolbanin Rezayee and Movahed, Emad},
  title = {Mesenchymal stem cell derived exosome promotes the viability of ameloblast-like cells},
  journal = {Nanomedicine Research Journal},
  year = {2023},
  volume = {8},
  number = {2},
  pages = {186--192},
  doi = {10.22034/nmrj.2023.02.008}
}
Kostenlos starten →